XML 55 R32.htm IDEA: XBRL DOCUMENT v3.19.1
Reportable segments
 12 Months Ended
Dec. 31, 2018
Disclosure of entity's operating segments [Abstract]  
Disclosure Of Entitys Reportable Segments Explanatory [Text Block]
Note 26
 
           
Reportable segments
 
26.1
Reportable segments
 
General information:
 
The Company revised its segment reporting as of December 31, 2017 and for the years ended December 31, 2017 and 2016 to make the following modifications:
 
1. Elimination of “Revenues from transactions with other operating segments of the same entity” amounts since the amounts presented in this line corresponded to transactions between companies within the same segment and did not represent inter-segment transactions.
 
2. Elimination of “Elimination of inter-segments amounts” column as this information intended to present consolidation adjustments that were not applicable for segment reporting. All the amounts presented in this column were reallocated into the “Unallocated amounts” column.
 
The amount of each item presented in each operating segment is equal to that reported to the highest authority that makes decisions regarding the operation, in order to decide on the allocation of resources to the defined segments and to assess its performance.
 
These operating segments mentioned are consistent with the way the Company is managed and how results will be reported by the Company. These segments reflect separate operating results that are regularly reviewed by the executive responsible for operational decisions in order to make decisions about the resources to be allocated to the segment and assess its performance (See Note 26.2).
 
The performance of each segment is measured based on net income and revenues.
 
Factors used to identify segments on which a report should be presented:
 
The segments covered in the report are strategic business units that offer different products and services. These are managed separately because each business requires different technology and marketing strategies.
 
Description of the types of products and services from which each reportable segment obtains its income from ordinary activities
 
The operating segments, which obtain income from ordinary activities, generate expenses and have its operating results reviewed on a regular basis by the highest authority who makes decisions regarding operations, relate to the following groups of products:
 
1.
Specialty plant nutrients
2.
Iodine and its derivatives
3.
Lithium and its derivatives
4.
Industrial chemicals
5.
       
Potassium
6.
Other products and services
 
Description of income sources for all the other segments
 
Information regarding assets, liabilities, profits and expenses that cannot be assigned to the segments indicated above, due to the nature of production processes, is included under the "Unallocated amounts” category of the disclosed information.
 
 
Basis of accounting for transactions between reportable segments
 
Description of the nature of the differences between measurements of results of reportable segments and the result of the entity before the expense or income tax expense of incomes and discontinued operations
 
The information reported in the segments is extracted from the Company’s consolidated financial statements and therefore there is no need to prepare reconciliations between the data mentioned above and those reported in the respective segments, according to what is stated in paragraph 28 of IFRS 8, "Operating Segments".
 
For the allocation of inventory valuation costs, we identify the direct expenses (can be directly allocated to products) and the common expenses (belong to coproduction processes, for example common leaching expenses for production of Iodine and Nitrates). Direct costs are directly allocated to the product and the common costs are distributed according to percentages that consider different variables in their determination, such as margins, rotation of inventories, revenue, production and etc.
 
The allocation of other common costs that are not included in the inventory valuation process, but go straight to the cost of sales, use similar criteria: the costs associated with a product or sales in particular are assigned to that particular product or sales, and the common costs associated with different products or business lines are allocated according to the sales.
 
Description of the nature of the differences between measurements of assets of reportable segments and the Company´s assets
Assets are not shown classified by segments, as this information is not readily available. Some of these assets are not separable by the type of activity by which they are affected since this information is not used by management in decision-making with respect to resources to be allocated to each defined segment. All assets are disclosed in the "unallocated amounts" category.
 
Description of the nature of the differences between measurements of liabilities of reportable segments and the Company’s liabilities
 
Liabilities are not shown classified by segments, as this information is not readily available. Some of these liabilities are not separable by the type of activity by which they are affected, since this information is not used by management in decision-making regarding resources to be allocated to each defined segment. All liabilities are disclosed in the "unallocated amounts" category.
 
26.2
Reportable
 segment disclosures:
 
Operating segment items
 
Specialty
plant
nutrients
 
 
Iodine and its
derivatives
 
 
Lithium and its
derivatives
 
 
Industrial
chemicals
 
 
Potassium
 
 
Other
products and
services
 
 
Reportable
segments
 
 
Operating
segments
 
 
Unallocated
amounts
 
 
Total
12/31/2018
 
 
 
ThUS$
 
 
ThUS$
 
 
ThUS$
 
 
ThUS$
 
 
ThUS$
 
 
ThUS$
 
 
ThUS$
 
 
ThUS$
 
 
ThUS$
 
 
ThUS$
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
 
 
781,750
 
 
 
324,972
 
 
 
734,801
 
 
 
108,268
 
 
 
267,474
 
 
 
48,538
 
 
 
2,265,803
 
 
 
2,265,803
 
 
 
 
 
 
 
2,265,803
 
Revenues from transactions with other operating segments of the same entity
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenues from external customers and 
transactions with other operating segments of the same entity
 
 
781,750
 
 
 
324,972
 
 
 
734,801
 
 
 
108,268
 
 
 
267,474
 
 
 
48,538
 
 
 
2,265,803
 
 
 
2,265,803
 
 
 
 
 
 
 
2,265,803
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Costs of sales
 
 
(613,267
)
 
 
(217,464
)
 
 
(316,875
)
 
 
(72,964
)
 
 
(217,386
)
 
 
(45,568
)
 
 
(1,483,524
)
 
 
(1,483,524
)
 
 
 
 
 
 
(1,483,524
)
Administrative expenses
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(118,126
)
 
 
(118,126
)
Interest expense
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(59,914
)
 
 
(59,914
)
Depreciation and amortization expense
 
 
(73,073
)
 
 
(45,280
)
 
 
(44,837
)
 
 
(16,041
)
 
 
(41,891
)
 
 
(377
)
 
 
(221,499
)
 
 
(221,499
)
 
 
 
 
 
 
(221,499
)
The entity’s interest in the profit or loss of associates and joint ventures accounted for by the equity method
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
6,351
 
 
 
6,351
 
Income tax expense, continuing operations
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(178,975
)
 
 
(178,975
)
Other items other than significant cash
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Income (loss) before taxes
 
 
168,483
 
 
 
107,508
 
 
 
417,926
 
 
 
35,304
 
 
 
50,088
 
 
 
2,970
 
 
 
782,279
 
 
 
782,279
 
 
 
(161,241
)
 
 
621,038
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss) from continuing operations
 
 
168,483
 
 
 
107,508
 
 
 
417,926
 
 
 
35,304
 
 
 
50,088
 
 
 
2,970
 
 
 
782,279
 
 
 
782,279
 
 
 
(340,216
)
 
 
442,063
 
Net income (loss) from discontinued operations
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
 
 
168,483
 
 
 
107,508
 
 
 
417,926
 
 
 
35,304
 
 
 
50,088
 
 
 
2,970
 
 
 
782,279
 
 
 
782,279
 
 
 
(340,216
)
 
 
442,063
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
4,268,094
 
 
 
4,268,094
 
Equity-accounted investees
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
111,549
 
 
 
111,549
 
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(15,028
)
 
 
(15,028
)
Increase of non-current assets
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
 
 
 
 
 
 
Liabilities
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
2,130,291
 
 
 
2,130,291
 
Impairment loss recognized in profit or loss
 
 
(2,227
)
 
 
(1,171
)
 
 
(243
)
 
 
(79
)
 
 
(3,006
)
 
 
(553
)
 
 
(7,279
)
 
 
(7,279
)
 
 
2,985
 
 
 
(4,294
)
Reversal of impairment losses recognized in profit or loss for the period
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
Cash flows from (used in) operating activities
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
524,1839
 
 
 
524,839
 
Cash flows from (used in) investing activities
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(187,004
)
 
 
(187,004
)
Cash flows from (used in) financing activities
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(387,313
)
 
 
(387,313
)
 
Operating segment items
 
 
Specialty
plant
nutrients
 
 
Iodine and its
derivatives
 
 
Lithium and its
derivatives
 
 
Industrial
chemicals
 
 
Potassium
 
 
Other
products and
services
 
 
Reportable
segments
 
 
Operating
segments
 
 
Unallocated
amounts
 
 
Total
12/31/2017
 
 
 
ThUS$
 
 
ThUS$
 
 
ThUS$
 
 
ThUS$
 
 
ThUS$
 
 
ThUS$
 
 
ThUS$
 
 
ThUS$
 
 
ThUS$
 
 
ThUS$
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
 
 
697,251
 
 
 
252,123
 
 
 
644,573
 
 
 
135,578
 
 
 
379,326
 
 
 
48,472
 
 
 
2,157,323
 
 
 
2,157,323
 
 
 
-
 
 
 
2,157,323
 
Revenues from transactions with other operating segments of the same entity
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
Revenues from external customers and transactions with other operating segments of the same entity
 
 
697,251
 
 
 
252,123
 
 
 
644,573
 
 
 
135,578
 
 
 
379,326
 
 
 
48,472
 
 
 
2,157,323
 
 
 
2,157,323
 
 
 
-
 
 
 
2,157,323
 
Costs of sales
 
 
(555,356
)
 
 
(199,808
)
 
 
(189,242
)
 
 
(91,753
)
 
 
(313,690
)
 
 
(44,973
)
 
 
(1,394,822
)
 
 
(1,394,822
)
 
 
-
 
 
 
(1,394,822
)
Administrative expenses
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(101,171
)
 
 
(101,171
)
Interest expense
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(50,124
)
 
 
(50,124
)
Depreciation and amortization expense
 
 
(73,702
)
 
 
(44,252
)
 
 
(18,036
)
 
 
(16,050
)
 
 
(88,130
)
 
 
(356
)
 
 
(240,526
)
 
 
(240,526
)
 
 
-
 
 
 
(240,526
)
The entity’s interest in the profit or loss of associates and joint ventures accounted for by the equity method
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
14,452
 
 
 
14,452
 
Income tax expense, continuing operations
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(166,173
)
 
 
(166,173
)
Other items other than significant cash
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Income (loss) before taxes
 
 
141,895
 
 
 
52,315
 
 
 
455,331
 
 
 
43,825
 
 
 
65,636
 
 
 
3,499
 
 
 
762,501
 
 
 
762,501
 
 
 
(167,911
)
 
 
594,590
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss) from continuing operations
 
 
141,895
 
 
 
52,315
 
 
 
455,331
 
 
 
43,825
 
 
 
65,636
 
 
 
3,499
 
 
 
762,501
 
 
 
762,501
 
 
 
(334,084
)
 
 
428,417
 
Net income (loss) from discontinued operations
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
 
 
141,895
 
 
 
52,315
 
 
 
455,331
 
 
 
43,825
 
 
 
65,636
 
 
 
3,499
 
 
 
762,501
 
 
 
762,501
 
 
 
(334,084
)
 
 
428,417
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
4,296,236
 
 
 
4,296,236
 
Equity-accounted investees
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
152,630
 
 
 
152,630
 
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-
 
 
 
-
 
Increase of non-current assets
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
Liabilities
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
2,048,768
 
 
 
2,048,768
 
Impairment loss recognized in profit or loss
 
 
(15,025
)
 
 
335
 
 
 
1,112
 
 
 
(3,546
)
 
 
(240
)
 
 
(219
)
 
 
(17,583
)
 
 
(17,583
)
 
 
(14,316
)
 
 
(31,899
)
Reversal of impairment losses recognized in profit or loss for the period
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
Cash flows from (used in) operating activities
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
758,272
 
 
 
758,227
 
Cash flows from (used in) investing activities
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(248,067
)
 
 
(248,067
)
Cash flows from (used in) financing activities
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(411,920
)
 
 
(411,920
)
                                         
 
 
 
12/31/2016
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Operating segment items
 
 
Specialty
plant
nutrients
 
 
Iodine and its
derivatives
 
 
Lithium and its
derivatives
 
 
Industrial
chemicals
 
 
Potassium
 
 
Other
products and
services
 
 
Reportable
segments
 
 
Operating
segments
 
 
Unallocated
amounts
 
 
Total
12/31/2016
 
 
 
ThUS$
 
 
ThUS$
 
 
ThUS$
 
 
ThUS$
 
 
ThUS$
 
 
ThUS$
 
 
ThUS$
 
 
ThUS$
 
 
ThUS$
 
 
ThUS$
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
 
 
623,853
 
 
 
231,144
 
 
 
514,627
 
 
 
104,137
 
 
 
403,323
 
 
 
62,238
 
 
 
1,939,322
 
 
 
1,939,322
 
 
 
-
 
 
 
1,939,322
 
Revenues from transactions with other operating segments of the same entity
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenues from external customers and transactions with other operating segments of the same entity
 
 
623,853
 
 
 
231,144
 
 
 
514,627
 
 
 
104,137
 
 
 
403,323
 
 
 
62,238
 
 
 
1,939,322
 
 
 
1,939,322
 
 
 
-
 
 
 
1,939,322
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Costs of sales
 
 
(478,074
)
 
 
(191,298
)
 
 
(175,616
)
 
 
(67,378
)
 
 
(359,477
)
 
 
(56,442
)
 
 
(1,328,285
)
 
 
(1,328,285
)
 
 
-
 
 
 
(1,328,285
)
Administrative expenses
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(88,436
)
 
 
(88,436
)
Interest expense
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(57,498
)
 
 
(57,498
)
Depreciation and amortization expense
 
 
(89,864
)
 
 
(35,958
)
 
 
(33,010
)
 
 
(12,666
)
 
 
(67,571
)
 
 
(10,612
)
 
 
(249,681
)
 
 
(249,681
)
 
 
(111
)
 
 
(249,792
)
The entity’s interest in the profit or loss of associates and joint ventures accounted for by the equity method
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
13,047
 
 
 
13,047
 
Income tax expense, continuing operations
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(132,965
)
 
 
(132,965
)
Other items other than significant cash
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
Income (loss) before taxes
 
 
145,779
 
 
 
39,846
 
 
 
339,011
 
 
 
36,759
 
 
 
43,846
 
 
 
5,796
 
 
 
611,037
 
 
 
611,037
 
 
 
(196,148
)
 
 
414,889
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss) from continuing operations
 
 
145,779
 
 
 
39,846
 
 
 
339,011
 
 
 
36,759
 
 
 
43,846
 
 
 
5,796
 
 
 
611,037
 
 
 
611,037
 
 
 
(329,113
)
 
 
281,924
 
Net income (loss) from discontinued operations
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
 
 
145,779
 
 
 
39,846
 
 
 
339,011
 
 
 
36,759
 
 
 
43,846
 
 
 
5,796
 
 
 
611,037
 
 
 
611,037
 
 
 
(329,113
)
 
 
281,924
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
4,217,980
 
 
 
4,217,980
 
Equity-accounted investees
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
133,140
 
 
 
133,140
 
Increase of non-current assets
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(107,268
)
 
 
(107,268
)
Liabilities
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
1,910,708
 
 
 
1,910,708
 
Impairment loss recognized in profit or loss
 
 
-
 
 
 
-
 
 
 
(251
)
 
 
-
 
 
 
-
 
 
 
(698
)
 
 
(949
)
 
 
(949
)
 
 
(39,595
)
 
 
(40,544
)
Reversal of impairment losses recognized in profit or loss for the period
 
 
133
 
 
 
325
 
 
 
-
 
 
 
233
 
 
 
2,216
 
 
 
-
 
 
 
2,907
 
 
 
2907
 
 
 
-
 
 
 
2,907
 
 
26.3
Statement of comprehensive income classified by reportable segments based on groups of products
 
 
 
12/31/2018
 
Items in the statement of comprehensive income
 
 
Specialty plant
nutrients
ThUS$
 
 
Iodine and its
derivatives
ThUS$
 
 
Lithium and its
derivatives
ThUS$
 
 
Industrial
chemicals
ThUS$
 
 
Potassium
 
ThUS$
 
 
 
Other products and
services
ThUS$
 
 
Corporate Unit
ThUS$
 
 
Total segments and
Corporate unit
ThUS$
 
Revenue
 
 
781,750
 
 
 
324,972
 
 
 
734,801
 
 
 
108,268
 
 
 
267,474
 
 
 
48,538
 
 
 
-
 
 
 
2,265,803
 
Cost of sales
 
 
(613,267
)
 
 
(217,464
)
 
 
(316,875
)
 
 
(72,964
)
 
 
(217,386
)
 
 
(45,568
)
 
 
-
 
 
 
(1,483,524
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gross profit
 
 
168,483
 
 
 
107,508
 
 
 
417,926
 
 
 
35,304
 
 
 
50,088
 
 
 
2,970
 
 
 
-
 
 
 
782,279
 
Other incomes by function
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
32,048
 
 
 
32,048
 
Administrative expenses
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(118,126
)
 
 
(118,126
)
Other expenses by function
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(36,907
)
 
 
(36,907
)
Deterioro de valor de ganancias y revisión de pérdidas por deterioro de valor (pérdidas por deterioro de valor) determinado de acuerdo con la NIIF 9
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
2,967
 
 
 
2,967
 
Other gains (losses)
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
6,404
 
 
 
6,404
 
Financial income
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
22,533
 
 
 
22,533
 
Financial costs
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(59,914
)
 
 
(59,914
)
interest in the profit or loss of associates and joint ventures accounted for by the equity method
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
6,351
 
 
 
6,351
 
Exchange differences
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(16,597
)
 
 
(16,597
)
Profit (loss) before taxes
 
 
168,483
 
 
 
107,508
 
 
 
417,926
 
 
 
35,304
 
 
 
50,088
 
 
 
2,970
 
 
 
(161,241
)
 
 
621,038
 
Income tax expense
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(178,975
)
 
 
(178,975
)
Profit (loss) from continuing operations
 
 
168,483
 
 
 
107,508
 
 
 
417,926
 
 
 
35,304
 
 
 
50,088
 
 
 
2,970
 
 
 
(340,216
)
 
 
442,063
 
Profit (loss) from discontinued operations
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
Profit (loss)
 
 
168,483
 
 
 
107,508
 
 
 
417,926
 
 
 
35,304
 
 
 
50,088
 
 
 
2,970
 
 
 
(340,216
)
 
 
442,063
 
Profit (loss), attributable to
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Profit (loss) attributable to the controller´s owners
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
439,830
 
Profit (loss) attributable to the non-controllers
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
2,233
 
Profit (loss)
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
442,063
 
 
 
 
12/31/2017
 
Items in the statement of comprehensive income
 
 
Specialty plant
nutrients
ThUS$
 
 
Iodine and its
derivatives
ThUS$
 
 
Lithium and its
derivatives
ThUS$
 
 
Industrial
chemicals
ThUS$
 
 
Potassium

ThUS$
 
 
Other products and
services
ThUS$
 
 
Corporate Unit
 
ThUS$
 
 
 
Total segments and
Corporate unit
ThUS$
 
Revenue
 
 
697,251
 
 
 
252,123
 
 
 
644,573
 
 
 
135,578
 
 
 
379,326
 
 
 
48,472
 
 
 
-
 
 
 
2,157,323
 
Cost of sales
 
 
(555,356
)
 
 
(199,808
)
 
 
(189,242
)
 
 
(91,753
)
 
 
(313,690
)
 
 
(44,973
)
 
 
-
 
 
 
(1,394,822
)
Gross profit
 
 
141,895
 
 
 
52,315
 
 
 
455,331
 
 
 
43,825
 
 
 
65,636
 
 
 
3,499
 
 
 
-
 
 
 
762,501
 
Other incomes by function
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
17,827
 
 
 
17,827
 
Administrative expenses
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(101,171
)
 
 
(101,171
)
Other expenses by function
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(53,600
)
 
 
(53,600
)
Other gains (losses)
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
543
 
 
 
543
 
Financial income
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
13,499
 
 
 
13,499
 
Financial costs
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(50,124
)
 
 
(50,124
)
Deterioro de valor de ganancias y revisión de pérdidas por deterioro de valor (pérdidas por deterioro de valor) determinado de acuerdo con la NIIF 9
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(8,038
)
 
 
(8,038
)
interest in the profit or loss of associates and joint ventures accounted for by the equity method
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
14,452
 
 
 
14,452
 
Exchange differences
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(1,299
)
 
 
(1,299
)
Profit (loss) before taxes
 
 
141,895
 
 
 
52,315
 
 
 
455,331
 
 
 
43,825
 
 
 
65,636
 
 
 
3,499
 
 
 
(167,911
)
 
 
594,590
 
Income tax expense
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(166,173
)
 
 
(166,173
)
Profit (loss) from continuing operations
 
 
141,895
 
 
 
52,315
 
 
 
455,331
 
 
 
43,825
 
 
 
65,636
 
 
 
3,499
 
 
 
(334,084
)
 
 
428,417
 
Profit (loss) from discontinued operations
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
Profit (loss)
 
 
141,895
 
 
 
52,315
 
 
 
455,331
 
 
 
43,825
 
 
 
65,636
 
 
 
3,499
 
 
 
(334,084
)
 
 
428,417
 
Profit (loss), attributable to
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
Profit (loss) attributable to the controller´s owners
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
427,697
 
Profit (loss) attributable to the non-controllers
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
720
 
Profit (loss)
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
428,417
 
 
 
 
12/31/2016
 
Items in the statement of comprehensive income
 
 
Specialty plant
nutrients
ThUS$
 
 
Iodine and its
derivatives
ThUS$
 
 
Lithium and its
derivatives
ThUS$
 
 
Industrial
chemicals
ThUS$
 
 
Potassium

ThUS$
 
 
Other products and
services
ThUS$
 
 
Corporate Unit
ThUS$
 
 
Total segments and
Corporate unit
ThUS$
 
Revenue
 
 
623,853
 
 
 
231,144
 
 
 
514,627
 
 
 
104,137
 
 
 
403,323
 
 
 
62,238
 
 
 
-
 
 
 
1,939,322
 
Cost of sales
 
 
(478,074
)
 
 
(191,298
)
 
 
(175,616
)
 
 
(67,378
)
 
 
(359,477
)
 
 
(56,442
)
 
 
-
 
 
 
(1,328,285
)
Gross profit
 
 
145,779
 
 
 
39,846
 
 
 
339,011
 
 
 
36,759
 
 
 
43,846
 
 
 
5,796
 
 
 
-
 
 
 
611,037
 
Other incomes by function
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
15,202
 
 
 
15,202
 
Administrative expenses
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(88,436
)
 
 
(88,436
)
Other expenses by function
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(82,533
)
 
 
(82,533
)
Other gains (losses)
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
679
 
 
 
679
 
Financial income
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
10,129
 
 
 
10,129
 
Financial costs
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(57,498
)
 
 
(57,498
)
Deterioro de valor de ganancias y revisión de pérdidas por deterioro de valor (pérdidas por deterioro de valor) determinado de acuerdo con la NIIF 9
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
7,198
 
 
 
7,198
 
interest in the profit or loss of associates and joint ventures accounted for by the equity method
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
13,047
 
 
 
13,047
 
Exchange differences
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
460
 
 
 
460
 
Profit (loss) before taxes
 
 
145,779
 
 
 
39,846
 
 
 
339,011
 
 
 
36,759
 
 
 
43,846
 
 
 
5,796
 
 
 
(196,148
)
 
 
414,889
 
Income tax expense
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(132,965
)
 
 
(132,965
)
Profit (loss) from continuing operations
 
 
145,779
 
 
 
39,846
 
 
 
339,011
 
 
 
36,759
 
 
 
43,846
 
 
 
5,796
 
 
 
(329,113
)
 
 
281,924
 
Profit (loss) from discontinued operations
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
Profit (loss)
 
 
145,779
 
 
 
39,846
 
 
 
339,011
 
 
 
36,759
 
 
 
43,846
 
 
 
5,796
 
 
 
(329,113
)
 
 
281,924
 
Profit (loss), attributable to
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Profit (loss) attributable to the controller´s owners
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
278,290
 
Profit (loss) attributable to the non-controllers
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
3,634
 
Profit (loss)
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
281,924
 
 
 
26.6
Segments by geographical areas as of December 31, 2018, 2017 and 2016
 
 
 
12/31/2018
 
Items
 
Chile
ThUS$
 
 
Latin America and
the Caribbean
ThUS$
 
 
Europe
ThUS$
 
 
North America
ThUS$
 
 
Asia and others
ThUS$
 
 
Total
ThUS$
 
Revenue
 
 
189,349
 
 
 
180,189
 
 
 
479,664
 
 
 
471,515
 
 
 
945,086
 
 
 
2,265,803
 
Investment accounted for under the equity method
 
 
(6,588
)
 
 
-
 
 
 
61,256
 
 
 
16,115
 
 
 
40,766
 
 
 
111,549
 
Intangible assets other than goodwill
 
 
110,544
 
 
 
-
 
 
 
386
 
 
 
152
 
 
 
77,201
 
 
 
188,283
 
Goodwill
 
 
22,535
 
 
 
86
 
 
 
11,373
 
 
 
724
 
 
 
-
 
 
 
34,718
 
Property, plant and equipment, net
 
 
1,445,349
 
 
 
347
 
 
 
4,451
 
 
 
3,098
 
 
 
1,578
 
 
 
1,454,823
 
Investment property
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
Other non-current assets
 
 
17,111
 
 
 
23
 
 
 
-
 
 
 
(892
)
 
 
11,298
 
 
 
27,540
 
Non-current assets that are not financial instruments
 
 
1,588,951
 
 
 
456
 
 
 
77,466
 
 
 
19,197
 
 
 
130,843
 
 
 
1,816,913
 
 
 
 
12/31/2017
 
Items
 
Chile
ThUS$
 
 
Latin America and
the Caribbean
ThUS$
 
 
Europe
ThUS$
 
 
North America
ThUS$
 
 
Asia and others
ThUS$
 
 
Total
ThUS$
 
Revenue
 
 
140,764
 
 
 
228,759
 
 
 
1,048,556
 
 
 
441,377
 
 
 
297,867
 
 
 
2,157,323
 
Investment accounted for under the equity method
 
 
(5,513
)
 
 
33,065
 
 
 
33,318
 
 
 
15,193
 
 
 
76,567
 
 
 
152,630
 
Intangible assets other than goodwill
 
 
113,152
 
 
 
-
 
 
 
453
 
 
 
182
 
 
 
-
 
 
 
113,787
 
Goodwill
 
 
23,731
 
 
 
6,290
 
 
 
11,374
 
 
 
724
 
 
 
2,058
 
 
 
44,177
 
Property, plant and equipment, net
 
 
1,421,141
 
 
 
313
 
 
 
3,857
 
 
 
2,469
 
 
 
1,574
 
 
 
1,429,354
 
Investment property
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
Other non-current assets
 
 
19,234
 
 
 
28
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
19,262
 
Non-current assets that are not financial instruments
 
 
1,571,745
 
 
 
39,696
 
 
 
49,002
 
 
 
18,568
 
 
 
80,199
 
 
 
1,759,210
 
 
 
 
12/31/2016
 
Items
 
Chile
ThUS$
 
 
Latin America and
the Caribbean
ThUS$
 
 
Europe
ThUS$
 
 
North America
ThUS$
 
 
Asia and others
ThUS$
 
 
Total
ThUS$
 
Revenue
 
 
162,477
 
 
 
240,607
 
 
 
411,807
 
 
 
416,380
 
 
 
708,051
 
 
 
1,939,323
 
Investment accounted for under the equity method
 
 
-
 
 
 
5,000
 
 
 
25,009
 
 
 
13,456
 
 
 
69,675
 
 
 
113,140
 
Intangible assets other than goodwill
 
 
109,227
 
 
 
-
 
 
 
-
 
 
 
211
 
 
 
1
 
 
 
109,439
 
Goodwill
 
 
23,731
 
 
 
86
 
 
 
11,373
 
 
 
724
 
 
 
2,058
 
 
 
37,972
 
Property, plant and equipment, net
 
 
1,526,992
 
 
 
234
 
 
 
3,521
 
 
 
2,536
 
 
 
1,483
 
 
 
1,534,766
 
Investment property
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
Other non-current assets
 
 
24,551
 
 
 
139
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
24,690
 
Non-current assets that are not financial instruments
 
 
1,684,501
 
 
 
5,459
 
 
 
39,903
 
 
 
16,927
 
 
 
73,217
 
 
 
1,820,007
 
 
 
26.8
 
       
Property, plant and equipment classified by geographical areas
 
The company's main production facilities are located near their mines and extraction facilities in northern Chile. The following table presents the main production facilities as of December 31, 2018 and December 31, 2017:
 
 
Location
 
Products
 
 
 
 
-
Pedro de Valdivia
:
Production of iodine and nitrate salts
-
María Elena
:
Production of iodine and nitrate salts
-
Coya Sur
:
Production of nitrate salts
-
Nueva Victoria
:
Production of iodine and nitrate salts
-
Salar de Atacama
:
Potassium chloride, lithium chloride, boric acid and potassium sulfate
-
Salar del Carmen
:
Production of lithium carbonate and lithium hydroxide
-
Tocopilla
:
Port facilities